A technique developed at Stanford for detecting the genetic profiles of tumor cells sifted from the bloodstream could offer a valuable tool for the clinic and the lab.
Profiling the genes of lung-tumor cells from patient blood samples may be a cheap, see noninvasive way to help doctors choose the right treatments, mind according to a study led by researchers at the Stanford University School of Medicine.
The new findings strengthen the hope that evaluating the genetic profiles of tumor cells circulating in the bloodstream could transform cancer care: first, ampoule by indicating the next chemotherapy or targeted therapy to use when tumors evolve resistance to previous drugs; and, second, by providing a way to study how tumors change over time. The new blood test is safer, cheaper, faster and more effective than alternative diagnostic approaches, said the researchers.
Read Full Article Here >>